Skip to content

Member

Valérie DELOGE

Patriots · France

Group
Patriots PfE
Country
France
Roll-call participation
96.0 %ⓘ of 620 roll calls in office · chamber median 90.6 % · whole term, final votes
With majority line
93.8 %ⓘ of 594 votes where the group had a line · Patriots median 80.0 %
More facts (5)
National party
RN Rassemblement national
In office
Since 16 Jul 2024
Against clear line
3 of 469 votesⓘ
Committees
AGRI, ENVI (substitute), SANT (substitute)
Member id
256886
More

Record

The member’s figures against the median of their group and of the chamber. Each vote counts the member in the group they belonged to that day.

Roll-call participation ⓘ

96.0 %

595 of 620 final votes while in office

Patriots median: 90.8 % (+5.2 pts)

Chamber median: 90.6 %

With majority line ⓘ

93.8 %

557 of 594 votes where their group had a line

Patriots median: 80.0 % (+13.8 pts)

Against clear line ⓘ

0.6 %

3 of 469 votes where their group had a clear line

0 opposite (for ↔ against), 3 abstained against the line

Abstention ⓘ

12.8 %

76 of 595 votes cast

Participation 96.0 % — Patriots median 90.8 %, 89 members.ⓘ
Data as a table
Participation among the 89 members of the Patriots with enough votes.
FigureParticipation
Valérie DELOGE96.0 %
Patriots median90.8 %
Lowest in the group44.2 %
Highest in the group99.7 %
Members89
With majority line 93.8 % — Patriots median 80.0 %, 89 members.ⓘ
Data as a table
With majority line among the 89 members of the Patriots with enough votes.
FigureWith majority line
Valérie DELOGE93.8 %
Patriots median80.0 %
Lowest in the group59.5 %
Highest in the group94.8 %
Members89
  • Whole term, 620 final votes; 620 of 794 decisions had a final vote recorded by name. The dots are the other members of Patriots; no ranks.
  • “No vote recorded” is not the same as absent: leave, illness and chairing the sitting look the same.
  • A group’s line is inferred from its members’ votes — Parliament publishes no whip.

Votes, 5 928

Export

Every roll-call vote of the term with the member’s position, newest first.

Result: for–against–abstained. Majority line: how most of the member’s group voted that day (“Tie” when no position won). ≠ group marks a vote otherwise than a clear line (at least two thirds, with at least 10 members voting) of their group.
DateDecision and voteResultPositionMajority line
16 Sept 2026Gender inequalities in health, specifically as regards gender-specific conditions Paragraph 46 — part 2 406 for, 214 against, 29 abstainedPosition: Against Majority line: Against
16 Sept 2026Gender inequalities in health, specifically as regards gender-specific conditions Paragraph 46 — part 1 470 for, 117 against, 63 abstainedPosition: For Majority line: Against
16 Sept 2026Gender inequalities in health, specifically as regards gender-specific conditions Paragraph 45 — part 3 334 for, 270 against, 34 abstainedPosition: Against Majority line: Against
16 Sept 2026Gender inequalities in health, specifically as regards gender-specific conditions Paragraph 45 — part 2 327 for, 272 against, 42 abstainedPosition: Against Majority line: Against
16 Sept 2026Gender inequalities in health, specifically as regards gender-specific conditions Paragraph 45 — part 1 433 for, 153 against, 53 abstainedPosition: For Majority line: Against
16 Sept 2026Gender inequalities in health, specifically as regards gender-specific conditions Separate vote on paragraph 44 349 for, 228 against, 79 abstainedPosition: Abstained Majority line: Against
16 Sept 2026Gender inequalities in health, specifically as regards gender-specific conditions Paragraph 43 — part 2 340 for, 285 against, 24 abstainedPosition: For Majority line: Against
16 Sept 2026Gender inequalities in health, specifically as regards gender-specific conditions Paragraph 43 — part 1 358 for, 210 against, 81 abstainedPosition: Abstained Majority line: Against
16 Sept 2026Gender inequalities in health, specifically as regards gender-specific conditions Separate vote on paragraph 41 362 for, 214 against, 75 abstainedPosition: Abstained Majority line: Against
16 Sept 2026Gender inequalities in health, specifically as regards gender-specific conditions Paragraph 24 — part 2 337 for, 303 against, 19 abstainedPosition: For Majority line: Against
16 Sept 2026Gender inequalities in health, specifically as regards gender-specific conditions Paragraph 24 — part 1 532 for, 42 against, 82 abstainedPosition: For Majority line: For
16 Sept 2026Gender inequalities in health, specifically as regards gender-specific conditions Paragraph 21 — part 2 433 for, 135 against, 65 abstainedPosition: For Majority line: For
16 Sept 2026Gender inequalities in health, specifically as regards gender-specific conditions Paragraph 21 — part 1 548 for, 37 against, 60 abstainedPosition: For Majority line: For
16 Sept 2026Gender inequalities in health, specifically as regards gender-specific conditions Amendment 8, adding text after paragraph 19 215 for, 294 against, 144 abstainedPosition: For Majority line: For
16 Sept 2026Gender inequalities in health, specifically as regards gender-specific conditions Amendment 7, adding text after paragraph 19 278 for, 304 against, 69 abstainedPosition: For Majority line: For
16 Sept 2026Gender inequalities in health, specifically as regards gender-specific conditions Paragraph 18 — part 3 399 for, 182 against, 72 abstainedPosition: Abstained Majority line: Abstained
16 Sept 2026Gender inequalities in health, specifically as regards gender-specific conditions Paragraph 18 — part 2 299 for, 354 against, 6 abstainedPosition: Against Majority line: Against
16 Sept 2026Gender inequalities in health, specifically as regards gender-specific conditions Paragraph 18 — part 1 435 for, 197 against, 22 abstainedPosition: Against Majority line: Against
16 Sept 2026Gender inequalities in health, specifically as regards gender-specific conditions Paragraph 16 — part 4 353 for, 224 against, 63 abstainedPosition: Abstained Majority line: Abstained
16 Sept 2026Gender inequalities in health, specifically as regards gender-specific conditions Paragraph 16 — part 3 330 for, 256 against, 57 abstainedPosition: Abstained Majority line: Against
16 Sept 2026Gender inequalities in health, specifically as regards gender-specific conditions Paragraph 16 — part 2 339 for, 302 against, 12 abstainedPosition: For Majority line: Against
16 Sept 2026Gender inequalities in health, specifically as regards gender-specific conditions Paragraph 16 — part 1 539 for, 20 against, 88 abstainedPosition: For Majority line: For
16 Sept 2026Gender inequalities in health, specifically as regards gender-specific conditions Paragraph 8 — part 3 388 for, 169 against, 88 abstainedPosition: Abstained Majority line: Against
16 Sept 2026Gender inequalities in health, specifically as regards gender-specific conditions Paragraph 8 — part 2 472 for, 133 against, 45 abstainedPosition: For Majority line: For
16 Sept 2026Gender inequalities in health, specifically as regards gender-specific conditions Paragraph 8 — part 1 501 for, 61 against, 74 abstainedPosition: For Majority line: For
16 Sept 2026Gender inequalities in health, specifically as regards gender-specific conditions Amendment 6, adding text after paragraph 6 194 for, 309 against, 145 abstainedPosition: For Majority line: For
16 Sept 2026Gender inequalities in health, specifically as regards gender-specific conditions Paragraph 6 — part 5 342 for, 280 against, 30 abstainedPosition: Against Majority line: Against
16 Sept 2026Gender inequalities in health, specifically as regards gender-specific conditions Paragraph 6 — part 4 601 for, 46 against, 9 abstainedPosition: For Majority line: For
16 Sept 2026Gender inequalities in health, specifically as regards gender-specific conditions Paragraph 3 — part 2 490 for, 141 against, 26 abstainedPosition: For Majority line: For
16 Sept 2026Gender inequalities in health, specifically as regards gender-specific conditions Paragraph 3 — part 1 406 for, 200 against, 35 abstainedPosition: Against Majority line: Against
16 Sept 2026An EU cardiovascular diseases strategy Final vote on the motion for a resolutionAdopted 545 for, 47 against, 75 abstainedPosition: Abstained Majority line: Abstained
16 Sept 2026Hybrid warfare and the protection of the EU’s territorial integrity and critical security and defence infrastructure Final vote — text as a wholeAdopted 470 for, 129 against, 62 abstainedPosition: Against Majority line: Against
16 Sept 2026Hybrid warfare and the protection of the EU’s territorial integrity and critical security and defence infrastructure Amendment 6, adding text after recital F 213 for, 426 against, 20 abstainedPosition: For Majority line: For
16 Sept 2026Hybrid warfare and the protection of the EU’s territorial integrity and critical security and defence infrastructure Amendment 12, adding text after paragraph 64 218 for, 434 against, 4 abstainedPosition: For Majority line: For
16 Sept 2026Hybrid warfare and the protection of the EU’s territorial integrity and critical security and defence infrastructure Amendment 11, adding text after paragraph 64 220 for, 432 against, 6 abstainedPosition: For Majority line: For
16 Sept 2026Hybrid warfare and the protection of the EU’s territorial integrity and critical security and defence infrastructure Amendment 10, adding text after paragraph 64 175 for, 438 against, 50 abstainedPosition: For Majority line: For
16 Sept 2026Hybrid warfare and the protection of the EU’s territorial integrity and critical security and defence infrastructure Amendment 9 to paragraph 64 205 for, 442 against, 10 abstainedPosition: For Majority line: For
16 Sept 2026Hybrid warfare and the protection of the EU’s territorial integrity and critical security and defence infrastructure Amendment 8 to paragraph 56 216 for, 439 against, 8 abstainedPosition: For Majority line: For
16 Sept 2026Hybrid warfare and the protection of the EU’s territorial integrity and critical security and defence infrastructure Amendment 7 to paragraph 35 231 for, 426 against, 9 abstainedPosition: For Majority line: For
16 Sept 2026Nuclear decommissioning assistance programme of the Ignalina nuclear power plant in Lithuania for the period 2028-2034 Final votePassed 625 for, 20 against, 22 abstainedPosition: For Majority line: For
16 Sept 2026EU-Norway Agreement on the participation of Norway in GOVSATCOM and in the Union Secure Connectivity Programme Final vote on the draft Council decisionConsent given 612 for, 8 against, 16 abstainedPosition: For Majority line: For
16 Sept 2026Instrument for Nuclear Safety Cooperation 2028-2034 Final votePassed 600 for, 21 against, 48 abstainedPosition: For Majority line: Tie
16 Sept 2026EU-Iceland Agreement on the participation of Iceland in GOVSATCOM and in the Union Secure Connectivity Programme Final vote on the draft Council decisionConsent given 631 for, 7 against, 15 abstainedPosition: For Majority line: For
16 Sept 2026EU-Switzerland Agreement on the transfer of passenger name record (PNR) data for the prevention, detection, investigation and prosecution of terrorist offences and serious crime Final vote on the draft Council decisionConsent given 549 for, 75 against, 30 abstainedPosition: For Majority line: For
16 Sept 2026EU-UK Agreement regarding cooperation on the application of their respective competition laws Final vote on the draft Council decisionConsent given 640 for, 5 against, 26 abstainedPosition: For Majority line: For
16 Sept 2026Establishing the Single Market and Customs Programme for the period 2028-2034 Final votePassed 496 for, 53 against, 125 abstainedPosition: Abstained Majority line: Abstained
16 Sept 2026Establishing the Single Market and Customs Programme for the period 2028-2034 Amendment 86 to Article 9, paragraph 2 131 for, 532 against, 10 abstainedPosition: For Majority line: For
16 Sept 2026Establishing the Single Market and Customs Programme for the period 2028-2034 Amendment 85, adding text after Article 8 138 for, 532 against, 4 abstainedPosition: For Majority line: For
16 Sept 2026Establishing the Single Market and Customs Programme for the period 2028-2034 Amendment 84 to Article 4, after paragraph 1 168 for, 505 against, 4 abstainedPosition: For Majority line: For
16 Sept 2026Defence readiness and facilitating defence investments and conditions for the defence industry (Omnibus V) Final vote on the provisional agreementPassed 530 for, 125 against, 12 abstainedPosition: For Majority line: For

Show all 50 votes on this page

Roll-call participation

One cell per sitting while in office, shaded by the share of that day’s roll calls the member voted in. The official attendance register is kept separately by Parliament.

No vote recorded on 3 of 80 sittings with roll calls.

"No vote recorded" is not the same as absent: leave, illness and chairing the sitting look the same.

Data as a table

Voting neighbours

Members who voted the same way most often in the roll calls they both took part in, within and outside the member’s group (group at the date of each vote), over all roll calls of the term.

At least 200 shared roll calls over at least six months in office together. Within = both sat in the same group on the date of the vote; a member who changed group can appear on both lists. Baseline = the median agreement of all pairs of members of the groups the two sat in on the date of each shared vote (within: the group they shared; outside: the two groups), weighted by the votes they shared in each combination.

Within Patriots

Agreement: roll calls where both cast the same position, of the roll calls both voted in while in the same group (“shared”); a count below 50 shared. Baseline: the median agreement of every pair of members of that group.
SelectMemberGroupCountryAgreementBaseline
Séverine WERBROUCK PatriotsFrance100 % of 4 957 shared74 %
Marie-Luce BRASIER-CLAIN PatriotsFrance100 % of 5 776 shared74 %
Jean-Paul GARRAUD PatriotsFrance100 % of 5 280 shared74 %
Julien LEONARDELLI PatriotsFrance100 % of 5 384 shared74 %
Anne-Sophie FRIGOUT PatriotsFrance100 % of 5 180 shared74 %
Marie DAUCHY PatriotsFrance100 % of 4 422 shared74 %
Fabrice LEGGERI PatriotsFrance100 % of 5 437 shared74 %
Gilles PENNELLE PatriotsFrance100 % of 5 645 shared74 %
Pierre-Romain THIONNET PatriotsFrance100 % of 5 378 shared74 %
André ROUGÉ PatriotsFrance100 % of 5 596 shared74 %

Show all 10 neighbours

Outside the group

Agreement: roll calls where both cast the same position, of the roll calls both voted in while in different groups (“shared”); a count below 50 shared. Baseline: the median agreement of every pair of members of the groups the two sat in on those votes (groups at the date, weighted by the votes shared in each combination).
SelectMemberGroupCountryAgreementBaseline
Sarah KNAFO ESNFrance78 % of 4 405 shared70 %
Guillaume PELTIER ECRFrance78 % of 5 043 shared68 %
Laurence TROCHU ECRFrance76 % of 5 544 shared68 %
Marion MARÉCHAL ECRFrance76 % of 4 939 shared68 %
Nicolas BAY ECRFrance76 % of 5 203 shared68 %
Luis-Vicențiu LAZARUS No groupRomania73 % of 4 780 shared51 %
Volker SCHNURRBUSCH changed group ESNGermany71 % of 4 435 shared69 %
René AUST ESNGermany71 % of 5 270 shared70 %
Hans NEUHOFF ESNGermany70 % of 4 298 shared70 %
Roberto VANNACCI changed group ESNItaly70 % of 2 197 shared68 %

Show all 10 neighbours

Work

Seats in committees, delegations and intergroups, and the dossiers the member leads, shadows or negotiates.

Seats

Body: the committee, delegation or intergroup, with its kind. Role: the member’s role in it. From, To: the dates of the seat (“now” while it lasts).
BodyRoleFromTo
Committee on Agriculture and Rural DevelopmentAGRI CommitteeMember19 Jul 2024now
Committee on the Environment, Climate and Food SafetyENVI CommitteeSubstitute20 Jan 2025now
Committee on Public HealthSANT CommitteeSubstitute23 Jan 2025now
Delegation for relations with the Federative Republic of BrazilD-BR DelegationMember19 Sept 2024now
Delegation for relations with the countries of Southeast Asia and the Association of Southeast Asian Nations (ASEAN)DASE DelegationSubstitute19 Sept 2024now
Delegation for relations with MercosurDMER DelegationSubstitute19 Sept 2024now
Intergroup on Christians in the Middle EastIG10-07 Intergroup / working groupMember20 Feb 2025now
Intergroup on Sustainable LivestockIG10-15 Intergroup / working groupMember31 Jan 2025now
Intergroup on the Welfare and Conservation of AnimalsIG10-27 Intergroup / working groupMember8 Jan 2025now
Committee on the Environment, Public Health and Food SafetyENVI CommitteeSubstitute19 Jul 202419 Jan 2025

Show all 11 seats

Dossiers

Dossier: the procedure the declaration names (“No dossier named” for a delegation without one). Role: rapporteur, shadow rapporteur, negotiator or delegation. Committee: the committee that appointed them. Date: of the declaration.
DossierRoleCommitteeDate
Modernised rules for patients’ rights in cross-border healthcareShadow rapporteurSANT30 Jul 2026
No dossier namedOfficial delegationSANT24 Jun 2026
Modernised rules for patients’ rights in cross-border healthcareShadow rapporteurSANT28 Apr 2026
No dossier namedOfficial delegationSANT7 Apr 2026
D-BR Mission to Brazil - 6 to 8 May 2026Official delegationD-BR1 Apr 2026
Amending Regulation (EU) 2018/848 as regards certain production, labelling and certification rules and certain rules on trade with third countriesShadow rapporteurAGRI17 Mar 2026
Production and marketing of plant reproductive material in the Union, amending Regulations (EU) 2016/2031, 2017/625 and 2018/848 of the European Parliament and of the Council, and repealing Council Directives 66/401/EEC, 66/402/EEC, 68/193/EEC, 2002/53/EC, 2002/54/EC, 2002/55/EC, 2002/56/EC, 2002/57/EC, 2008/72/EC and 2008/90/EC (Regulation on plant reproductive material)Shadow rapporteurAGRI10 Mar 2026
Amending Regulation (EU) No 1308/2013 as regards the school fruit, vegetables and milk scheme (‘EU school scheme’), sectoral interventions, the creation of a protein sector, requirements for hemp, the possibility for marketing standards for cheese, protein crops and meat, application of additional import duties, rules on the availability of supplies in time of emergencies and severe crisis and securitiesShadow rapporteurAGRI10 Mar 2026
Empowering France to accede to the Inter-American Convention for the Protection and Conservation of Sea TurtlesShadow rapporteurENVI2 Feb 2026
Restructuring the Union framework for the taxation of energy products and electricity (recast)Shadow rapporteur for an opinionAGRI22 Jul 2025

Show all 18 dossier roles

Topics they work on (model-assigned)

Counts: dossiers they spoke on, led or amended, and their questions and motions.

In the chamber

Speeches and statements in plenary debates, newest first; the verbatim report is on Parliament’s site.

43 contributions recorded; 5 on behalf of their group; 52 minutes of speaking time.

Date: the sitting. Debate: the item debated, and the group when they spoke on its behalf. Kind: speech or written statement, with speaking time. Verbatim: the verbatim report on Parliament’s site.
DateDebateKindVerbatim
7 Jul 2026Presentation of the programme of activities of the Irish Presidency (debate) Speech · 1 minRead
19 May 2026Presentation of the Fertilisers Action Plan (debate) Speech · 1 minRead
30 Apr 2026How to secure a sustainable future for the EU livestock sector in light of the need to ensure food security, farmers’ resilience and the challenges posed by animal diseases? (debate) on behalf of PatriotsSpeech · 1 minRead
29 Apr 2026EU strategy in response to the ongoing Middle East crisis, its implications on energy prices and the availability of fertilizers (debate) Speech · 1 minRead
27 Apr 2026One-minute speeches on matters of political importance Speech · 1 minRead
25 Mar 2026One-minute speeches on matters of political importance Speech · 1 minRead
9 Feb 2026One-minute speeches on matters of political importance Speech · 1 minRead
19 Jan 2026Framework for strengthening the availability and security of supply of critical medicinal products as well as the availability of, and accessibility of, medicinal products of common interest (debate) Speech · 1 minRead
19 Jan 2026Framework for strengthening the availability and security of supply of critical medicinal products as well as the availability of, and accessibility of, medicinal products of common interest (debate) Speech · 1 minRead
19 Jan 2026Framework for strengthening the availability and security of supply of critical medicinal products as well as the availability of, and accessibility of, medicinal products of common interest (debate) Speech · 1 minRead

Show all 40 recent contributions

Questions and motions, 123

Parliamentary questions and motions for resolutions the member authored or co-signed, newest first.

Date: tabled. Title: the question or motion, with its id. Kind: written question or motion for a resolution, with the number of co-authors. Answer: the date of the answer to a question.
DateTitleKindAnswer
9 Sept 2026The 28th regime/EU Inc.: can the Commission guarantee the soundness of its legal basis? P-10-2026-003589Priority written questionwith 17 co-authorsNot yet answered
7 Sept 2026Financing alternatives to Canadair E-10-2026-003520Written questionwith 5 co-authorsNot yet answered
10 Aug 2026Putting an end to AdBlue-related fire engine breakdowns E-10-2026-003245Written questionwith 13 co-authorsNot yet answered
5 Aug 2026Coherence of EU policies on nature restoration, vineyard restructuring and forest fire prevention E-10-2026-003209Written questionwith 5 co-authorsNot yet answered
4 Aug 2026Effectiveness of rescEU and availability of resources to tackle ongoing fires in France P-10-2026-003198Priority written questionwith 5 co-authorsNot yet answered
23 Jul 2026MOTION FOR A RESOLUTION on the spread of Sargassum and its impact on the outermost regions, notably Guadeloupe and Martinique B-10-2026-0372Motion for a resolutionwith 15 co-authors—
17 Jul 2026Adapting EU energy performance policies in the light of extreme heat episodes O-10-2026-000032Oral questionwith 35 co-authorsNot yet answered
17 Jul 2026Reshoring of the flax sector: industrial and strategic challenges for the EU E-10-2026-003046Written questionwith 8 co-authors3 Sept 2026
16 Jul 2026Traditional Speciality Guaranteed (TSG) ‘Fleur de Sel’ E-10-2026-003007Written questionwith 8 co-authors26 Aug 2026
14 Jul 2026PPWR Regulation: simplification or yet another mess of red tape? E-10-2026-002900Written questionwith 8 co-authors1 Sept 2026

Show all 123 questions and motions

Amendments tabled in committee, 165

Committee amendment documents that carry amendments by the member, with how many are theirs.

Date: of the amendment document. Text amended: the dossier and the document’s id. Committee: where the amendments were tabled. Amendments: how many in the document are the member’s.
DateText amendedCommitteeAmendments
11 Sept 2026Modernised rules for patients’ rights in cross-border healthcare SANT-AM-792154 SANT8
11 Sept 2026Modernised rules for patients’ rights in cross-border healthcare SANT-AM-792014 SANT9
28 Jul 2026Amending Regulations (EU) 2017/745 and (EU) 2017/746 as regards simplifying and reducing the burden of the rules on medical devices and in vitro diagnostic medical devices, and amending Regulation (EU) 2022/123 as regards the support of the European Medicines Agency for the expert panels on medical devices and Regulation (EU) 2024/1689 as regards the list of Union harmonisation legislation referred to in its Annex I SANT-AM-791891 SANT24
28 Jul 2026Amending Regulations (EU) 2017/745 and (EU) 2017/746 as regards simplifying and reducing the burden of the rules on medical devices and in vitro diagnostic medical devices, and amending Regulation (EU) 2022/123 as regards the support of the European Medicines Agency for the expert panels on medical devices and Regulation (EU) 2024/1689 as regards the list of Union harmonisation legislation referred to in its Annex I SANT-AM-791890 SANT29
28 Jul 2026Amending Directives 2008/98/EC, 2010/75/EU, (EU) 2015/2193 and (EU) 2024/1785 of the European Parliament and of the Council as regards simplification of some requirements and reduction of administrative burden ENVI-AM-791123 ENVI14
28 Jul 2026Amending Regulations (EU) 2017/745 and (EU) 2017/746 as regards simplifying and reducing the burden of the rules on medical devices and in vitro diagnostic medical devices, and amending Regulation (EU) 2022/123 as regards the support of the European Medicines Agency for the expert panels on medical devices and Regulation (EU) 2024/1689 as regards the list of Union harmonisation legislation referred to in its Annex I SANT-AM-791887 SANT25
23 Jul 2026Proposal for a Regulation of the European Parliament and of the Council establishing a framework of measures for the acceleration of industrial capacity and decarbonisation in strategic sectors and amending Regulations (EU) 2018/1724, (EU) 2024/1735 and (EU) 2024/3110 ENVI-AM-791125 ENVI20
23 Jul 2026Proposal for a Regulation of the European Parliament and of the Council establishing a framework of measures for the acceleration of industrial capacity and decarbonisation in strategic sectors and amending Regulations (EU) 2018/1724, (EU) 2024/1735 and (EU) 2024/3110 ENVI-AM-791124 ENVI20
20 Jul 2026Amending Directives 2008/98/EC, 2010/75/EU, (EU) 2015/2193 and (EU) 2024/1785 of the European Parliament and of the Council as regards simplification of some requirements and reduction of administrative burden ENVI-AM-790834 ENVI11
17 Jul 2026on the proposal for a regulation of the European Parliament and of the Council establishing the conditions for the implementation of the Union support to the Common Agriculture Policy for the period from 2028 to 2034 AGRI-AM-790898 AGRI1

Show all 165 amendment documents

Connections

Dossiers they lead or shadow, committees, party, delegation and other related pages.

Political group

National delegation

  • Delegation France National delegation

Sources & citation

Where the facts on this page come from, and how to cite it.

Data source
Licensed CC BY 4.0.
Data version
data version f37e5638cded (25 Sept 2026) · methods: group-at-date v1, participation v1, abstention v1, loyalty v1, against-clear v1, cohesion v1, agreement v1, group-agreement v1, winning-side v1, similar-votes v1, scope v1, data-version v1 · methods
Retrieved
25 September 2026

Cite as

EU Parl Watch Research (2026). “Valérie DELOGE”. Member record. memberId 256886. EU Parl Watch Research. https://news.eu-parl.st-solutions.dev/members/256886?page=4&scope=final&vscope=all (retrieved 25 September 2026). Official source: Member’s profile, European Parliament, https://www.europarl.europa.eu/meps/en/256886. Data: EP Open Data: member record, https://data.europarl.europa.eu/api/v2/meps/256886?format=application%2Fld%2Bjson (CC BY 4.0); data version f37e5638cded (25 Sept 2026) · methods: group-at-date v1, participation v1, abstention v1, loyalty v1, against-clear v1, cohesion v1, agreement v1, group-agreement v1, winning-side v1, similar-votes v1, scope v1, data-version v1.
BibTeX
@misc{epw-member-256886,
  author = {{EU Parl Watch Research}},
  title = {{Valérie DELOGE}},
  year = {2026},
  howpublished = {\url{https://news.eu-parl.st-solutions.dev/members/256886?page=4&scope=final&vscope=all}},
  url = {https://news.eu-parl.st-solutions.dev/members/256886?page=4&scope=final&vscope=all},
  urldate = {2026-09-25},
  publisher = {EU Parl Watch Research},
  note = {Member record. memberId 256886. Official source: https://www.europarl.europa.eu/meps/en/256886. Data: EP Open Data: member record (CC BY 4.0); data version f37e5638cded (25 Sept 2026) · methods: group-at-date v1, participation v1, abstention v1, loyalty v1, against-clear v1, cohesion v1, agreement v1, group-agreement v1, winning-side v1, similar-votes v1, scope v1, data-version v1}
}